BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34956183)

  • 1. Praziquantel Treatment of
    Nono JK; Mpotje T; Mosala P; Aziz NA; Musaigwa F; Hlaka L; Spangenberg T; Brombacher F
    Front Immunol; 2021; 12():748387. PubMed ID: 34956183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.
    Tweyongyere R; Mawa PA; Emojong NO; Mpairwe H; Jones FM; Duong T; Dunne DW; Vennervald BJ; Katunguka-Rwakishaya E; Elliott AM
    BMC Infect Dis; 2009 Mar; 9():32. PubMed ID: 19296834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.
    Mohammed ES; Nakamura R; Kalenda YD; Deloer S; Moriyasu T; Tanaka M; Fujii Y; Kaneko S; Hirayama K; Ibrahim AI; El-Seify MA; Metwally AM; Hamano S
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008518. PubMed ID: 32915790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy using Pentostam and Praziquantel improves lesion healing and parasite resolution in BALB/c mice co-infected with Leishmania major and Schistosoma mansoni.
    Khayeka-Wandabwa C; Kutima H; Nyambati VC; Ingonga J; Oyoo-Okoth E; Karani L; Jumba B; Githuku K; Anjili CO
    Parasit Vectors; 2013 Aug; 6():244. PubMed ID: 23968249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oral therapy on Mansonial Schistosomiasis using single dose of Balanites aegyptiaca fruits and praziquantel.
    Koko WS; Abdalla HS; Galal M; Khalid HS
    Fitoterapia; 2005 Jan; 76(1):30-4. PubMed ID: 15664459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMMUNOPROTECTION OF SOLUBLE EGG ANTIGENS AND PRAZIQUANTEL IN CHALLENGED MURINE SCHISTOSOMIASIS MANSONI.
    El-Aal NFA; Mohammed FA; Magdy M
    J Egypt Soc Parasitol; 2017 Apr; 47(1):1-12. PubMed ID: 30157327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
    Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
    Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
    Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
    Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel.
    Liang YS; Coles GC; Doenhoff MJ; Southgate VR
    Int J Parasitol; 2001 Sep; 31(11):1227-35. PubMed ID: 11513892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.
    Black CL; Muok EM; Mwinzi PN; Carter JM; Karanja DM; Secor WE; Colley DG
    J Infect Dis; 2010 Aug; 202(3):399-405. PubMed ID: 20560767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosoma mansoni in mice: the pattern of primary cercarial exposure determines whether a secondary infection post-chemotherapy elicits a T helper 1- or a T helper 2-associated immune response.
    Farah IO; Johansson M; Lövgren-Bengtson K; Hau J
    Scand J Immunol; 2000 Mar; 51(3):237-43. PubMed ID: 10736092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with adult
    El-Aswad BEW; Harba NM; Moharm IM; Mahmoud SF
    J Helminthol; 2019 Jan; 94():e26. PubMed ID: 30702051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
    Keiser J; Manneck T; Vargas M
    J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni.
    Mokbel KEM; Baiuomy IR; Sabry AEA; Mohammed MM; El-Dardiry MA
    Sci Rep; 2020 Sep; 10(1):15742. PubMed ID: 32978497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insufficiency of annual praziquantel treatment to control Schistosoma mansoni infections in adult women: A longitudinal cohort study in rural Tanzania.
    Mishra P; Colombe S; Paul N; Mlingi J; Tosiri I; Aristide C; Gao J; Kashangaki P; Nagai H; Kalluvya SE; de Dood CJ; Corstjens PL; Mngara J; van Dam GJ; Downs JA
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007844. PubMed ID: 31751333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to Schistosoma mansoni schistosomula antigens.
    Egesa M; Lubyayi L; Jones FM; van Diepen A; Chalmers IW; Tukahebwa EM; Bagaya BS; Hokke CH; Hoffmann KF; Dunne DW; Elliott AM; Yazdanbakhsh M; Wilson S; Cose S
    Parasite Immunol; 2018 Dec; 40(12):e12591. PubMed ID: 30239012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.
    Mwinzi PN; Ganley-Leal L; Black CL; Secor WE; Karanja DM; Colley DG
    J Infect Dis; 2009 Jan; 199(2):272-9. PubMed ID: 19072134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
    Sabra AN; Botros SS
    J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the therapeutic efficacy of praziquantel in murine Schistosomiasis mansoni using silica nanocarrier.
    Tawfeek GM; Baki MHA; Ibrahim AN; Mostafa MAH; Fathy MM; Diab MSEDM
    Parasitol Res; 2019 Dec; 118(12):3519-3533. PubMed ID: 31673833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
    Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
    APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.